Alpha 2.0
Login Register
» Articles » PMID: 34598430

Vaccination Strategies Against SARS-CoV-2: General Impact on the Development of the Pandemic

Overview
Journal Rev Esp Quimioter
Specialty Pharmacology
Date 2021 Oct 2
PMID 34598430
Citations 1
Authors
A Gil de Miguel
R Gil-Prieto
Affiliations
Soon will be listed here.
Abstract

In this article, we will review the main vaccination strategies currently being implemented by the health authorities and analyze the main vaccines authorized by the EMA. As practical aspects of vaccination, we must make it clear that until collective immunity is reached, the preventive measures being implemented will have to be kept in place. In the words of the WHO Accelerator Project, There is no time to waste in the fight against COVID-19. No one is safe until everyone is safe.

Citing Articles

Decoding trends in mRNA vaccine research: A comprehensive bibliometric study.

Zhang C, Wang Y, Peng J, Wen X, Zhang Y, Li K Hum Vaccin Immunother. 2024; 20(1):2355037.

PMID: 38813652 PMC: 11141478. DOI: 10.1080/21645515.2024.2355037.

References
1.
Widge A, Rouphael N, Jackson L, Anderson E, Roberts P, Makhene M . Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination. N Engl J Med. 2020; 384(1):80-82. PMC: 7727324. DOI: 10.1056/NEJMc2032195. View
2.
Polack F, Thomas S, Kitchin N, Absalon J, Gurtman A, Lockhart S . Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med. 2020; 383(27):2603-2615. PMC: 7745181. DOI: 10.1056/NEJMoa2034577. View
3.
Voysey M, Clemens S, Madhi S, Weckx L, Folegatti P, Aley P . Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2020; 397(10269):99-111. PMC: 7723445. DOI: 10.1016/S0140-6736(20)32661-1. View